A-193 A-193 (Loxapine Succinate 25 mg)
Pill with imprint A-193 A-193 is Green / Green, Capsule-shape and has been identified as Loxapine succinate 25 mg. It is supplied by Actavis Pharma, Inc..
Loxapine is used in the treatment of agitation; agitated state; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A-193 A-193
Loxapine succinate
- Imprint:
- A-193 A-193
- Strength:
- 25 mg
- Color:
- Green / Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 52152-0193
More about loxapine
- Loxapine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 6 Reviews – Add your own review/rating
- Drug class: miscellaneous antipsychotic agents
Consumer resources
- Loxapine
- Loxapine inhalation
- Loxapine Capsules
- Loxapine Inhalation Powder
- Loxapine (Advanced Reading)
- Loxapine Inhalation (Advanced Reading)
Other brands: Loxitane, Adasuve
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
